South Korea Sleep Apnea Therapeutic Devices Market Overview, 2031

The South Korean Sleep Apnea Therapeutic Devices Market is experiencing steady growth, supported by increased awareness of sleep‑related breathing issues and robust technology adoption in both clinical and consumer markets. The country holds a significant position in the Asia‑Pacific region, highlighting its sophisticated healthcare system, tech-savvy population, and growing investments in respiratory care innovations. A key feature of the South Korean market is its technology-led adoption. Advanced PAP devices that feature smart connectivity, noise-reduction technology, and real-time compliance monitoring are quickly becoming popular, particularly among urban users who appreciate convenience and high-quality medical electronics. Local and companies like ResMed, Philips Healthcare, Fisher & Paykel, along with emerging regional innovators, compete by offering distinct products with a strong focus on compact and user-friendly designs intended for home use. In terms to traditional devices, there is a noticeable momentum for wearable tech and AI-powered sleep monitoring solutions. For example, Samsung Electronics’ Galaxy Watch, which can detect sleep apnea, has received MFDS certification as a software medical device in Korea and has also earned other international approvals, demonstrating the merging of consumer technology with clinical monitoring for early diagnosis and patient involvement. This technological merging broadens the market's scope and enhances the digital health ecosystem, aligning with Korea’s national focus on preventive and personalized healthcare. Adherence to regulations from the Ministry of Food and Drug Safety MFDS ensures that the therapeutic devices available in South Korea adhere to strict safety, quality, and performance standards, building clinician trust and aiding adoption in both hospitals and home care.

According to the research report, "South Korea Sleep Apnea Therapeutic Devices Market Overview, 2031," published by Bonafide Research, the South Korea Sleep Apnea Therapeutic Devices market is expected to reach a market size of more than 190 Million by 2031. The Sleep Apnea Therapeutic Devices Market in South Korea is expanding at a varied rate, influenced by demographic changes, advancements in healthcare, and the growth of digital health technologies. More than just its market size, the landscape of opportunity is shaped by Korea’s quickly aging population and its proactive adoption of connected health innovations. As the elderly population who are more susceptible to obstructive sleep apnea continues to increase, the need for effective therapeutic devices, including PAP machines and diagnostic equipment, is progressively rising. Trends in innovation play a crucial role in the vibrancy of South Korea’s market. The focus of local research and development is increasingly on smart gadgets that not only provide treatment but also connect with mobile and cloud services for remote tracking and patient feedback. This wave of digitalization aligns with the rising adoption of telemedicine and AI-driven analysis to improve access to sleep health services, especially for those hesitant about traditional sleep lab evaluations. Wearable tracking technologies and mobile-connected PAP devices empower healthcare professionals to better tailor treatment suggestions and boost long-term adherence key elements considering that compliance significantly impacts treatment results. Leading international companies like ResMed, Philips Healthcare, and Fisher & Paykel have a strong presence in the South Korean therapy market, often partnering with local distributors and health providers to customize their products for the preferences of Korean consumers. 

South Korea sleep apnea therapeutic devices market by product type is divided into positive airway pressure PAP devices, oral appliances, adaptive servo-ventilators, nasal devices, accessories & consumables, diagnostic devices & others. In South Korea, the market for sleep apnea devices categorized by product type highlights the country’s increasing emphasis on efficient respiratory treatments and early detection methods in light of the growing occurrence and knowledge of sleep-related breathing issues. Within this therapeutic category, Positive Airway Pressure PAP devices are essential for clinical treatment of Obstructive Sleep Apnea OSA, thanks to their demonstrated success and strong advocacy from healthcare professionals and distributors like LMT Korea, which collaborates with brands to improve high-quality PAP availability in various healthcare environments. In South Korea, PAP devices consist of CPAP and BiPAP systems designed for comfort and noise reduction, tailored to patient needs in homecare situations. Oral devices MADs are becoming more popular as practical, non-CPAP options for individuals with mild to moderate OSA or those finding it difficult to adhere to continuous PAP therapy. Korean manufacturers and regional clinics are increasingly providing MAD options, including locally patented items that have MFDS approval and are covered by some health insurance plans, which helps improve access for patients hesitant to use PAP devices. Adaptive Servo-Ventilators ASV and similar sophisticated ventilation aids are less commonly used but can be found in specialized hospital departments for more complicated cases, including certain presentations of central sleep apnea. Nasal devices, such as EPAP systems, remain specialized but are valued for their simplicity and usability in mild cases or as supplementary options in more comprehensive treatment approaches.

South Korea sleep apnea therapeutic devices market by indication is divided into obstructive sleep apnea, central sleep apnea and mixed/complex sleep apnea. In South Korea, Obstructive Sleep Apnea OSA is the leading medical reason fueling the demand for therapeutic devices, corresponding with prevalence figures that identify OSA as the most common variant of sleep apnea and a significant public health issue in East Asia. Regional research and industry documents reveal that one in five Koreans might show signs of sleep apnea, positioning OSA as the main focus for PAP, MAD, and similar treatments. The significant occurrence of OSA leads to widespread utilization of PAP devices notably CPAP and APAP systems which are regarded as first-line treatments in moderate to severe instances due to their capacity to keep the upper airway open and diminish apneic episodes during sleep. This trend is bolstered by the strong preference of clinicians and established treatment guidelines in Korean sleep clinics. Central Sleep Apnea CSA makes up a smaller percentage of identified cases and is usually found in patients with associated neurological or heart issues. Due to its lower frequency compared to OSA, CSA tends to receive more focused attention mainly in specialized respiratory departments and advanced treatment centers where modern breathing support technologies, like Adaptive Servo-Ventilators ASV, are accessible. Although ASV machines are not commonly used in general practices, they serve as significant treatment choices for complicated central breathing issues and mixed types. Mixed or complex sleep apnea characterized by the presence of both OSA and CSA traits necessitates careful diagnostic distinction, often requiring overnight polysomnography in specialized sleep clinics in Korea.

South Korea sleep apnea therapeutic devices market by end user is divided into home care settings / individuals, sleep laboratories & clinics and hospitals. In South Korea, users of sleep apnea treatments are spread across home care environments, sleep labs and clinics, and hospitals, illustrating a healthcare system that combines advanced diagnosis with a patient-focused approach to long-term management. Home care settings and individual users represent one of the fastest growing areas, fueled by a rising understanding of sleep apnea’s health effects and the advantages of at-home PAP treatments. Smaller, quieter devices and improved mask designs have increased the comfort of PAP usage, leading many patients to move directly from clinical identification to home-based treatment. The rise of telemedicine and remote adherence tracking further bolsters this sector, allowing specialists to modify treatment plans and monitor compliance without the need for frequent in-person appointments. Sleep labs and clinics play a crucial role in the treatment process in South Korea. These facilities conduct thorough polysomnography PSG and respiratory function assessments that provide precise diagnoses and severity evaluations, which are vital for determining the correct therapy be it PAP, MAD, or advanced ventilators for complex cases. Hospitals, particularly large tertiary and university medical centers, incorporate sleep apnea treatment within a wider framework of respiratory and cardiovascular care. Patients with severe OSA or al health issues receive comprehensive support, which includes starting PAP therapy, ASV assistance for specialized conditions, and multidisciplinary consultations with pulmonologists, cardiologists, and neurologists. While hospitals may not reach the same level of homecare device placements for long-term use, surgical interventions and advanced care decisions usually begin in hospital settings, subsequently influencing outpatient and home management strategies.
v
"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Sleep Apnea Therapeutic Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product Type
• Positive Airway Pressure (PAP) Devices
• Oral Appliances (Mandibular Advancement Devices - MADs)
• Adaptive Servo-Ventilators (ASV)
• Nasal Devices (Expiratory Positive Airway Pressure - EPAP)
• Accessories & Consumables
• Diagnostic Devices & others
By Indication
• Obstructive Sleep Apnea (OSA)
• Central Sleep Apnea (CSA)
• Mixed/Complex Sleep Apnea
By End-User
• Home Care Settings / Individuals
• Sleep Laboratories & Clinics
• Hospitals
By Distribution Channel
• Direct Sales
• Retail & Online Sales"